Original Article

HFE Gene Mutation Among Turkish Patients with Type 2 Diabetes Mellitus

Volume 17 · Issue 4 Publish Date: December 1, 2013
Full Text PDF
DOI
Erdem Akbal
Çanakkale Onsekiz Mart University, Department of Gastroenterology, Çanakkale, Turkey
Fahri Güneş
Çanakkale Onsekiz Mart University, Internal Medicine, Çanakkale, Turkey
Mehmet Aşık
Çanakkale Onsekiz Mart University, Endocrinology, Çanakkale, Turkey
Mustafa Özbek
Ministry of Health, Ankara Dışkapı Yıldırım Beyazıt Education and Research Hospital, Department of Endocrinology and Metabolism, Ankara, Turkey
Kemal Üreten
Kırıkkale University, Department of Rheumatology, Kırıkkale, Turkey
Mustafa Altınbaş
Ministry of Health, Dışkapı Yıldırım Beyazıt Education and Research Hospital, Department of Oncology, Ankara, Turkey
Akbal, E., Güneş, F., Aşık, M., Özbek, M., Üreten, K., & Altınbaş, M. (2013). HFE Gene Mutation Among Turkish Patients with Type 2 Diabetes Mellitus. Endocrinology Research and Practice, 17(4), 89–91. https://doi.org/10.4274/Tjem.2309
Full Text Full Text PDF

Abstract

ABSTRACT

Purpose: Hereditary haemochromatosis (HH) is a genetic disease with autosomal recessive trait. Recent studies demonstrated the importance of C282Y gene mutation in the aetiology of HH. Free iron accumulating in pancreas deteriorates insulin secretion and synthesis which can lead to insulin resistance and the development of type 2 diabetes mellitus (T2DM) in patients with HH. There has been no study determining the prevalence of haemochromatosis gene (HFE) mutations and HH in diabetic patients in Turkey. We planned this study in order to investigate the C282Y and H63D mutation that cause HH in T2DM.
Material and Method: In this study, we included185 patients with T2DM. Patients older than thirty-five years, not taking vitamin supplementation, iron preparates and/or oral contraceptives and those without any signs of active bleeding were included while patients with any infectious, systemic or immune disease were excluded from the study. Serum transferrin saturation (TS), ferritin, iron, and total iron binding capacity levels were measured after 12 hours of fasting.
Results: Ten (5.4%) cases with TS of more than 45% were detected at the first evaluation. The test was repeated in those cases and 6 patients with TS of more than 45% were left according to the second measurement. H63D and C282Y gene polymorphisms were not present in these patients.
Discussion: We did not find any correlation between the existence of T2DM and HFE polymorphisms. We assume that screening for HH in T2DM in our population is not needed.

Article Info
Published In
Journal Endocrinology Research and Practice
Volume / Issue Volume 17 · Issue 4
Pages 89-91
History
Published Online December 1, 2013
Copyright
Affiliations
Erdem Akbal
Çanakkale Onsekiz Mart University, Department of Gastroenterology, Çanakkale, Turkey
Fahri Güneş
Çanakkale Onsekiz Mart University, Internal Medicine, Çanakkale, Turkey
Mehmet Aşık
Çanakkale Onsekiz Mart University, Endocrinology, Çanakkale, Turkey
Mustafa Özbek
Ministry of Health, Ankara Dışkapı Yıldırım Beyazıt Education and Research Hospital, Department of Endocrinology and Metabolism, Ankara, Turkey
Kemal Üreten
Kırıkkale University, Department of Rheumatology, Kırıkkale, Turkey
Mustafa Altınbaş
Ministry of Health, Dışkapı Yıldırım Beyazıt Education and Research Hospital, Department of Oncology, Ankara, Turkey
Cite this Article
Akbal, E., Güneş, F., Aşık, M., Özbek, M., Üreten, K., & Altınbaş, M. (2013). HFE Gene Mutation Among Turkish Patients with Type 2 Diabetes Mellitus. Endocrinology Research and Practice, 17(4), 89–91. https://doi.org/10.4274/Tjem.2309
Outlines